![\"Clocks\"](\"http:\/\/online.wsj.com\/media\/clocks_D_20090406140901.jpg\")
A pharma company wants to sell a prescription drug to fight jet lag; the FDA isn’t quite ready to make the call.<\/p>\nA pharma company wants to sell a prescription drug to fight jet lag; the FDA isn’t quite ready to make the call.<\/p>\n
Cephalon applied for the approval earlier this year for its drug Nuvigil. The company said a study<\/a> of 427 people who flew from the Eastern U.S. to France showed that those who took the drug had less jet lag than those who took placebo. <\/p>\n A decision from the FDA was expected this month, but the company said<\/a> yesterday that the FDA had pushed back the decision deadline by a few months.<\/p>\n Nuvigil and another Cephalon drug, Provigil, are both approved to “improve wakefulness” in people with certain sleep problems. The drugs work in a similar way, though Nuvigil has longer-lasting effects. Cephalon has been raising the price of Provigil — which could face generic competition in 2012 — in what looks like an effort to get people to switch to Nuvigil, which has patent protection through 2023.<\/p>\n The company raised the wholesale price of Provigil by 29% in late November, to $13.62 per pill, Dow Jones Newswires reported<\/a> this morning. Five years ago, Provigil cost $5.53 per pill. Nuvigil costs $8.98 per pill, according to DJ Newswires.<\/p>\n A pharma company wants to sell a prescription drug to fight jet lag; the FDA isn’t quite ready to make the call. Cephalon applied for the approval earlier this year for its drug Nuvigil. The company said a study of 427 people who flew from the Eastern U.S. to France showed that those who took […]<\/p>\n","protected":false},"author":650,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-97976","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/97976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/650"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=97976"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/97976\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=97976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=97976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=97976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}<\/img><\/a>
\n<\/img><\/a><\/p>\n
\n<\/img><\/a>
<\/img><\/a>
<\/img><\/a>
<\/img><\/a>
<\/img><\/a>\n<\/div>\n
<\/p>\n","protected":false},"excerpt":{"rendered":"